Genetics of mycobacterial adaptation to selective pressure of antituberculous compounds dissected at the in vitro and in vivo levels

BACKGROUND: Different spontaneous mutations emerge in Mycobacterium tuberculosis and those beneficial for bacterial survival are selected leading to bacterial drug resistance, tolerance and ultimately - persistence. AIM: To study M. tuberculosis genetic variation in response to selective pressure of...

Full description

Saved in:
Bibliographic Details
Main Authors: Igor Mokrousov, Tatiana Vinogradova, Natalia Solovieva, Ivaylo Slavchev, Marine Dogonadze, Sergei Chekrygin, Dmitry Polev, Anna Vyazovaya, Georgi Dobrikov, Violina T. Angelova, Violeta Valcheva, Viacheslav Zhuravlev
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:Journal of Global Antimicrobial Resistance
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2213716524001954
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850059819159912448
author Igor Mokrousov
Tatiana Vinogradova
Natalia Solovieva
Ivaylo Slavchev
Marine Dogonadze
Sergei Chekrygin
Dmitry Polev
Anna Vyazovaya
Georgi Dobrikov
Violina T. Angelova
Violeta Valcheva
Viacheslav Zhuravlev
author_facet Igor Mokrousov
Tatiana Vinogradova
Natalia Solovieva
Ivaylo Slavchev
Marine Dogonadze
Sergei Chekrygin
Dmitry Polev
Anna Vyazovaya
Georgi Dobrikov
Violina T. Angelova
Violeta Valcheva
Viacheslav Zhuravlev
author_sort Igor Mokrousov
collection DOAJ
description BACKGROUND: Different spontaneous mutations emerge in Mycobacterium tuberculosis and those beneficial for bacterial survival are selected leading to bacterial drug resistance, tolerance and ultimately - persistence. AIM: To study M. tuberculosis genetic variation in response to selective pressure of antibiotics and derived compounds in vivo and in vitro, to gain insight into resistance mechanisms. METHODS: C57Bl/6 mice were infected with different MDR clinical strains followed by treatment with moxifloxacin, linezolid, and bedaquiline. Bacterial isolates were recovered from the lungs of euthanized mice after 2 and 5.5 months of treatment. For in vitro study, H37Rv reference strain was cultured under elevated concentrations of new compounds, and resistant clones were subjected to whole-genome sequencing as single or pooled colonies (metagenomics-like approach). RESULTS: The complete treatment course significantly reduced the bacterial burden of the lungs of mice; no resistance mutations emerged even negligibly. The in vitro mutagenesis study revealed M. tuberculosis response to nitrofuranyl amide through multiple pathways (Rv0224c, fbiC, iniA, Rv1592c genes), reportedly counteracting oxidative and nitrosative stress. Classical mutagenesis approach revealed several genes involved in M. tuberculosis response to isoniazid derivatives: glpK frameshift mutation linked to reversible drug tolerance and nonsynonymous mutation in Rv3755c located nearby the ABC transporter/efflux genes. CONCLUSIONS: M. tuberculosis exhibited a complex multifaceted genetic response to nitrofuranyl amide and isoniazid derivatives. Nevertheless, when mice infected with various multidrug-resistant strains were treated with scientifically validated chemotherapy regimens, no new resistance mutations developed, and the treatment outcome was favorable. This indicates a promising strategy for combating drug-resistant tuberculosis.
format Article
id doaj-art-d537b8ec67f64439904f37f0c4d84e81
institution DOAJ
issn 2213-7165
language English
publishDate 2024-12-01
publisher Elsevier
record_format Article
series Journal of Global Antimicrobial Resistance
spelling doaj-art-d537b8ec67f64439904f37f0c4d84e812025-08-20T02:50:47ZengElsevierJournal of Global Antimicrobial Resistance2213-71652024-12-01396710.1016/j.jgar.2024.10.018Genetics of mycobacterial adaptation to selective pressure of antituberculous compounds dissected at the in vitro and in vivo levelsIgor Mokrousov0Tatiana Vinogradova1Natalia Solovieva2Ivaylo Slavchev3Marine Dogonadze4Sergei Chekrygin5Dmitry Polev6Anna Vyazovaya7Georgi Dobrikov8Violina T. Angelova9Violeta Valcheva10Viacheslav Zhuravlev11Laboratory of Molecular Epidemiology and Evolutionary Genetics, St. Petersburg Pasteur Institute, St. Petersburg, RussiaDepartment of Basic Medicine, St. Petersburg Research Institute of Phthisiopulmonology, St. Petersburg, RussiaDepartment of Basic Medicine, St. Petersburg Research Institute of Phthisiopulmonology, St. Petersburg, RussiaInstitute of Organic Chemistry with Center of Phytochemistry, Bulgarian Academy of Sciences, Sofia, BulgariaDepartment of Basic Medicine, St. Petersburg Research Institute of Phthisiopulmonology, St. Petersburg, RussiaResource center “Biobank Center”, St. Petersburg State University, St. Petersburg, RussiaMetagenomic Research Group, St. Petersburg Pasteur Institute, St. Petersburg, RussiaLaboratory of Molecular Epidemiology and Evolutionary Genetics, St. Petersburg Pasteur Institute, St. Petersburg, RussiaInstitute of Organic Chemistry with Center of Phytochemistry, Bulgarian Academy of Sciences, Sofia, BulgariaFaculty of Pharmacy, Medical University of Sofia, Sofia, BulgariaThe Stephan Angeloff Institute of Microbiology, Bulgarian Academy of Sciences, Sofia, BulgariaDepartment of Basic Medicine, St. Petersburg Research Institute of Phthisiopulmonology, St. Petersburg, RussiaBACKGROUND: Different spontaneous mutations emerge in Mycobacterium tuberculosis and those beneficial for bacterial survival are selected leading to bacterial drug resistance, tolerance and ultimately - persistence. AIM: To study M. tuberculosis genetic variation in response to selective pressure of antibiotics and derived compounds in vivo and in vitro, to gain insight into resistance mechanisms. METHODS: C57Bl/6 mice were infected with different MDR clinical strains followed by treatment with moxifloxacin, linezolid, and bedaquiline. Bacterial isolates were recovered from the lungs of euthanized mice after 2 and 5.5 months of treatment. For in vitro study, H37Rv reference strain was cultured under elevated concentrations of new compounds, and resistant clones were subjected to whole-genome sequencing as single or pooled colonies (metagenomics-like approach). RESULTS: The complete treatment course significantly reduced the bacterial burden of the lungs of mice; no resistance mutations emerged even negligibly. The in vitro mutagenesis study revealed M. tuberculosis response to nitrofuranyl amide through multiple pathways (Rv0224c, fbiC, iniA, Rv1592c genes), reportedly counteracting oxidative and nitrosative stress. Classical mutagenesis approach revealed several genes involved in M. tuberculosis response to isoniazid derivatives: glpK frameshift mutation linked to reversible drug tolerance and nonsynonymous mutation in Rv3755c located nearby the ABC transporter/efflux genes. CONCLUSIONS: M. tuberculosis exhibited a complex multifaceted genetic response to nitrofuranyl amide and isoniazid derivatives. Nevertheless, when mice infected with various multidrug-resistant strains were treated with scientifically validated chemotherapy regimens, no new resistance mutations developed, and the treatment outcome was favorable. This indicates a promising strategy for combating drug-resistant tuberculosis.http://www.sciencedirect.com/science/article/pii/S2213716524001954Mycobacterium tuberculosisdrug resistancedrug tolerancemutagenesisspontaneous mutationmurine model
spellingShingle Igor Mokrousov
Tatiana Vinogradova
Natalia Solovieva
Ivaylo Slavchev
Marine Dogonadze
Sergei Chekrygin
Dmitry Polev
Anna Vyazovaya
Georgi Dobrikov
Violina T. Angelova
Violeta Valcheva
Viacheslav Zhuravlev
Genetics of mycobacterial adaptation to selective pressure of antituberculous compounds dissected at the in vitro and in vivo levels
Journal of Global Antimicrobial Resistance
Mycobacterium tuberculosis
drug resistance
drug tolerance
mutagenesis
spontaneous mutation
murine model
title Genetics of mycobacterial adaptation to selective pressure of antituberculous compounds dissected at the in vitro and in vivo levels
title_full Genetics of mycobacterial adaptation to selective pressure of antituberculous compounds dissected at the in vitro and in vivo levels
title_fullStr Genetics of mycobacterial adaptation to selective pressure of antituberculous compounds dissected at the in vitro and in vivo levels
title_full_unstemmed Genetics of mycobacterial adaptation to selective pressure of antituberculous compounds dissected at the in vitro and in vivo levels
title_short Genetics of mycobacterial adaptation to selective pressure of antituberculous compounds dissected at the in vitro and in vivo levels
title_sort genetics of mycobacterial adaptation to selective pressure of antituberculous compounds dissected at the in vitro and in vivo levels
topic Mycobacterium tuberculosis
drug resistance
drug tolerance
mutagenesis
spontaneous mutation
murine model
url http://www.sciencedirect.com/science/article/pii/S2213716524001954
work_keys_str_mv AT igormokrousov geneticsofmycobacterialadaptationtoselectivepressureofantituberculouscompoundsdissectedattheinvitroandinvivolevels
AT tatianavinogradova geneticsofmycobacterialadaptationtoselectivepressureofantituberculouscompoundsdissectedattheinvitroandinvivolevels
AT nataliasolovieva geneticsofmycobacterialadaptationtoselectivepressureofantituberculouscompoundsdissectedattheinvitroandinvivolevels
AT ivayloslavchev geneticsofmycobacterialadaptationtoselectivepressureofantituberculouscompoundsdissectedattheinvitroandinvivolevels
AT marinedogonadze geneticsofmycobacterialadaptationtoselectivepressureofantituberculouscompoundsdissectedattheinvitroandinvivolevels
AT sergeichekrygin geneticsofmycobacterialadaptationtoselectivepressureofantituberculouscompoundsdissectedattheinvitroandinvivolevels
AT dmitrypolev geneticsofmycobacterialadaptationtoselectivepressureofantituberculouscompoundsdissectedattheinvitroandinvivolevels
AT annavyazovaya geneticsofmycobacterialadaptationtoselectivepressureofantituberculouscompoundsdissectedattheinvitroandinvivolevels
AT georgidobrikov geneticsofmycobacterialadaptationtoselectivepressureofantituberculouscompoundsdissectedattheinvitroandinvivolevels
AT violinatangelova geneticsofmycobacterialadaptationtoselectivepressureofantituberculouscompoundsdissectedattheinvitroandinvivolevels
AT violetavalcheva geneticsofmycobacterialadaptationtoselectivepressureofantituberculouscompoundsdissectedattheinvitroandinvivolevels
AT viacheslavzhuravlev geneticsofmycobacterialadaptationtoselectivepressureofantituberculouscompoundsdissectedattheinvitroandinvivolevels